SCHEMBL27865693

SCHEMBL27865693

Cc1cc(-c2ccc3ncc(N4CCN(c5ccc(CN)cc5)CC4)nc3c2)cc(C)c1O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.42
RAB9A P51151 6/20 0.42
MAPT P10636 6/20 0.42
ALDH1A1 P00352 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
GAA P10253 1/20 0.42
HPGD P15428 1/20 0.42
NFKB1 P19838 1/20 0.42
HTT P42858 1/20 0.42
NFKB2 Q00653 1/20 0.42
RELA Q04206 1/20 0.42
KDM4E B2RXH2 3/20 0.41
NPSR1 Q6W5P4 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
JAK1 P23458 1/20 0.38
FYN P06241 1/20 0.37
HRH4 Q9H3N8 2/20 0.37
HTR3A P46098 1/20 0.37
PTPN11 Q06124 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12812476 0.89 MAPT (0.44) NPC1RAB9AMAPTALDH1A1SMN1; SMN2
SCHEMBL1442150 0.88 MAPT (0.46) NPC1RAB9AMAPTALDH1A1SMN1; SMN2
SCHEMBL10179077 0.86 NPC1 (0.58) NPC1RAB9AMAPTALDH1A1SMN1; SMN2
SCHEMBL10179663 0.86 MAPT (0.59) NPC1RAB9AMAPTALDH1A1SMN1; SMN2
SCHEMBL1443036 0.85 NPC1 (0.45) NPC1RAB9AMAPTALDH1A1SMN1; SMN2
SCHEMBL1442956 0.84 MAPT (0.61) NPC1RAB9AMAPTALDH1A1SMN1; SMN2
SCHEMBL1441950 0.84 CHEK1 (0.43) NPC1RAB9AMAPTALDH1A1SMN1; SMN2
SCHEMBL1443575 0.83 RAB9A (0.49) NPC1RAB9AMAPTALDH1A1SMN1; SMN2
SCHEMBL1442658 0.83 MAPT (0.43) NPC1RAB9AMAPTALDH1A1SMN1; SMN2
SCHEMBL1442650 0.82 HRH4 (0.56) NPC1RAB9ASMN1; SMN2KDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102596932-A Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors BAYER SCHERING PHARMA AG 2012-07-18 CN claimed